FDA label
What is Gralise used for?
Gralise contains gabapentin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “GRALISE is indicated for the management of postherpetic neuralgia.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Gralise?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Gralise, tablet, film coated
Indications and Usage, quoted from the label by Almatica Pharma LLC (NDA022544). Cross-references to other label sections are left out.
GRALISE is indicated for the management of postherpetic neuralgia.
GRALISE is not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration.
Source: DailyMed label, set id 466273b1-c9fc-3930-c94b-aa11394d5140, version 7, effective June 30, 2026. NDC 52427-803, one of 5 listings for this product.
Questions
What is Gralise used for?
The FDA label says: “GRALISE is indicated for the management of postherpetic neuralgia.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Gralise
- Is Gralise a controlled substance?Federal schedule
- Generic for GraliseFDA Orange Book
- What is Gabapentin used for?FDA label uses
- Is Gabapentin a controlled substance?Federal schedule
- Generic for NeurontinFDA Orange Book
- Gralise Medicare Part D coverageBy plan and state
- NDC 52427-803Gralise NDC record
- NDC 52427-804Gralise NDC record
- NDC 52427-806Gralise NDC record